Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CELLULAR SENESCENCE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | CELLULAR SENESCENCE |
| Linked Hypotheses | 6 hypotheses |
Knowledge base pages for this entity
graph TD
CELLULAR_SENESCENCE["CELLULAR SENESCENCE"]
style CELLULAR_SENESCENCE fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
CELLULAR_SENESCENCE -->|"involved_in"| Cardiac_Aging["Cardiac Aging"]
CELLULAR_SENESCENCE -->|"causes"| Cell_Cycle_Arrest(Cell Cycle Arrest)
CELLULAR_SENESCENCE -->|"causes"| Apoptosis_Resistance(Apoptosis Resistance)
CELLULAR_SENESCENCE -->|"causes"| Senescence_Associated_Secretor(Senescence-Associated Secretory Phenotype)
CELLULAR_SENESCENCE -->|"causes"| cell_cycle_arrest(cell cycle arrest)
CELLULAR_SENESCENCE -->|"promotes"| pro_inflammatory_molecules["pro-inflammatory molecules"]
CELLULAR_SENESCENCE -->|"expressed in"| Dopaminergic_Neurons["/Dopaminergic Neurons/"]
CELLULAR_SENESCENCE -->|"mediates"| Senescence_Associated_Secretom["Senescence-Associated Secretome"]
CELLULAR_SENESCENCE -->|"involved_in"| Biological_Aging["Biological Aging"]
CELLULAR_SENESCENCE -->|"contributes to"| Aging["Aging"]
Lipid_Accumulation["Lipid Accumulation"] -->|"causes"| CELLULAR_SENESCENCE
AMPK([AMPK]) -->|"regulates"| CELLULAR_SENESCENCE
LIPID_ACCUMULATION["LIPID ACCUMULATION"] -->|"causes"| CELLULAR_SENESCENCE
Telomere_Dysfunction["Telomere Dysfunction"] -->|"causes"| CELLULAR_SENESCENCE
PGAM5([PGAM5]) -->|"modulates"| CELLULAR_SENESCENCE
Mitochondrial_Dysfunction["Mitochondrial Dysfunction"] -->|"causes"| CELLULAR_SENESCENCE
P53([P53]) -->|"promotes"| CELLULAR_SENESCENCE
cGAS_STING["cGAS/STING"] -->|"regulates"| CELLULAR_SENESCENCE
cGAS_STING_signaling_pathway["cGAS/STING signaling pathway"] -->|"regulates"| CELLULAR_SENESCENCE
Ginkgetin{"Ginkgetin"} -.->|"prevents"| CELLULAR_SENESCENCE| Target | Relation | Type | Str |
|---|---|---|---|
| cell cycle arrest | causes | phenotype | 0.95 |
| pro-inflammatory molecules | promotes | pathway | 0.95 |
| senescence-associated secretory phenotype | drives | phenotype | 0.95 |
| DOPAMINERGIC NEURONS | associated_with | entity | 0.95 |
| Cardiac Aging | involved_in | process | 0.95 |
| Cell Cycle Arrest | causes | phenotype | 0.95 |
| Apoptosis Resistance | causes | phenotype | 0.95 |
| Senescence-Associated Secretory Phenotype | causes | phenotype | 0.95 |
| aging | associated_with | process | 0.95 |
| ALZHEIMER'S DISEASE | causes | disease | 0.95 |
| PARKINSON'S DISEASE | causes | disease | 0.95 |
| Inflammation | promotes | process | 0.95 |
| Neurodegeneration | associated_with | disease | 0.95 |
| Alzheimer'S Disease | contributes_to | disease | 0.95 |
| Alzheimer's Disease | contributes_to | disease | 0.95 |
| Alzheimer Disease | contributes_to | disease | 0.95 |
| Alzheimer'S Disease Pathology | mediates | mechanism | 0.92 |
| senescence-related disorders | causes | disease | 0.90 |
| neurodegenerative disorders | contributes_to | disease | 0.90 |
| Dopaminergic Neurons | expressed_in | cell_type | 0.90 |
| Senescence-Associated Secretome | mediates | pathway | 0.90 |
| Biological Aging | involved_in | process | 0.90 |
| Aging | contributes_to | process | 0.90 |
| Chronic Aging-Related Diseases | contributes_to | disease | 0.90 |
| Senescence Biomarkers | biomarker_for | biomarker | 0.90 |
| Chronic Inflammation | contributes_to | process | 0.90 |
| Aging | involved_in | process | 0.90 |
| Biological Aging | mediates | process | 0.90 |
| Senescence-Associated Secretory Phenotype | mediates | phenotype | 0.90 |
| Senescence-Associated Secretory Phenotype | associated_with | phenotype | 0.90 |
| Inflammaging | contributes_to | process | 0.90 |
| Neuroinflammation | contributes_to | process | 0.90 |
| Embryonic Development | involved_in | process | 0.90 |
| Wound Healing | involved_in | process | 0.90 |
| Obesity | associated_with | disease | 0.90 |
| Inflammation | causes | process | 0.90 |
| NEURODEGENERATION | contributes_to | process | 0.90 |
| AGING | associated_with | process | 0.90 |
| Cellular Dysfunction | contributes_to | phenotype | 0.90 |
| Neuroinflammation | promotes | process | 0.90 |
| Neurodegenerative Diseases | contributes_to | disease | 0.90 |
| Osteoarthritis | contributes_to | disease | 0.88 |
| Cognitive Deficits | causes | phenotype | 0.88 |
| Myocardial Ischemia And Infarction | involved_in | disease | 0.87 |
| neurodegeneration | promotes | disease | 0.85 |
| Heart Failure | involved_in | disease | 0.85 |
| Myocardial Ischemia | involved_in | disease | 0.85 |
| Myocardial Infarction | involved_in | disease | 0.85 |
| Myocardial Ischemia and Infarction | involved_in | disease | 0.85 |
| Aging | associated_with | process | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| cGAS/STING signaling pathway | regulates | pathway | 0.95 |
| Lipid Accumulation | causes | process | 0.95 |
| AMPK | regulates | protein | 0.95 |
| LIPID ACCUMULATION | causes | entity | 0.95 |
| Telomere Dysfunction | causes | mechanism | 0.95 |
| PGAM5 | modulates | protein | 0.95 |
| Mitochondrial Dysfunction | causes | process | 0.95 |
| Ginkgetin | associated_with | compound | 0.95 |
| MIR-302B | associated_with | gene | 0.95 |
| P53 | promotes | protein | 0.95 |
| cGAS/STING | regulates | pathway | 0.95 |
| Ginkgetin | inhibits | compound | 0.95 |
| Mir-302B | associated_with | biomarker | 0.95 |
| Cgas/Sting Signaling | regulates | pathway | 0.95 |
| Lipid Accumulation | promotes | process | 0.95 |
| Dasatinib | inhibits | drug | 0.95 |
| Quercetin | inhibits | compound | 0.95 |
| aging | drives | process | 0.95 |
| Alzheimer'S Disease | associated_with | disease | 0.95 |
| SRT2104 | suppresses | drug | 0.93 |
| Ginkgetin | prevents | drug | 0.92 |
| STING | regulates | protein | 0.92 |
| SQSTM1 | prevents | gene | 0.90 |
| oncogene-induced stress | causes | process | 0.90 |
| lipid accumulation | drives | process | 0.90 |
| senolytics | targets | drug | 0.90 |
| apoptosis resistance | associated_with | phenotype | 0.90 |
| H₂O₂ | causes | compound | 0.90 |
| autophagy | suppresses | process | 0.90 |
| Glucocerebrosides | causes | compound | 0.90 |
| Obesity | associated_with | phenotype | 0.90 |
| Metabolic Reprogramming | associated_with | process | 0.90 |
| PLIN2 | associated_with | entity | 0.90 |
| Prediabetes | associated_with | disease | 0.90 |
| SIRT1 | regulates | gene | 0.90 |
| mitophagy | protects_against | process | 0.90 |
| IL23R | biomarker_for | protein | 0.90 |
| iPSC Reprogramming | associated_with | process | 0.90 |
| Partial Reprogramming | associated_with | process | 0.90 |
| Lysosomal Impairment | associated_with | process | 0.90 |
| MTOR | involved_in | gene | 0.90 |
| Microglia | involved_in | cell_type | 0.90 |
| Astrocytes | involved_in | cell_type | 0.90 |
| SDA-2026-04-01-gap-013 | investigates | analysis | 0.90 |
| Intermittent Fasting | modulates | drug | 0.90 |
| CDKN1A | associated_with | protein | 0.90 |
| CDKN2A | associated_with | protein | 0.90 |
| BHB | suppresses | compound | 0.90 |
| STING | promotes | protein | 0.88 |
| Hayflick Limit | biomarker_for | biomarker | 0.88 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.790
neurodegeneration | 2026-04-03 | 34 hypotheses Top: 0.736
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||